# DESCRIPTION

## TECHNICAL FIELD

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION OF THE INVENTION

### I. DEFINITIONS

### II. DERIVATIVES

### III. EMBODIMENTS FOR TARGETING STAT3

### IV. TARGETING CANCER STEM CELLS

### V. COMBINATION THERAPY

### VI. PHARMACEUTICAL COMPOSITIONS

### VII. KITS OF THE INVENTION

## EXAMPLES

### Exemplary Materials and Methods

### Identification by VLS of Compounds that Blocked Stat3 Binding to its Phosphopeptide Ligand and Inhibited IL-6-Mediated Phosphorylation of STAT3

### Compound-Mediated Inhibition of Ligand-Stimulated Phosphorylation of STAT3 is Specific for Stat3 Vs. Stat1

### Sequence Analysis and Molecular Modeling of the Interaction of Each Compound with the Stat3 Vs. Stat1 SH2 Domain

### Example 5

## PUBLICATIONS

